HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Petition Suggests Rx-Only Vitamin B6 At 10-MG And Up In US, Add Warning To All Doses

Executive Summary

Emery Pharma's citizen petition discusses potential health risks from vitamin B6 use, saying “there is a significant lack of data to justify supplementation in individuals with adequate B6 levels, entirely.”

You may also be interested in...



‘Valisure Scenario’ Plan Should Be Ready In Consumer Health, Personal Care Firms’ Tool Kits

“What started a couple years ago with the discovery of nitrosamine in blood pressure and heart medicine has since evolved to benzene in hand sanitizer and sunscreen,” says Sedgwick International’s Amanda Combs about “Valisure scenario.”

Ireland Sets Maximum Levels For Vitamins As Supplement Popularity Grows

As more and more dietary supplements flood the Irish market to meet the demand created by the COVID-19 pandemic, Ireland has joined a number of its EU neighbors in setting maximum levels for certain vitamins and minerals to protect consumer health.

Funding Doubles Women’s Health Firm Perelel’s Support, Boosts Odyssey Elixir Energy Visibility

Perelel doubles its support and makes $10m pledge to women’s health research groups; Odyssey Wellness starts boosting brand visibility for energy drinks with lion’s mane and cordyceps mushrooms.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS151819

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel